Send to

Choose Destination
Immunology. 2019 Dec 27. doi: 10.1111/imm.13169. [Epub ahead of print]

SLAMF9 is found on select subsets of antigen-presenting cells and promotes resistance to Salmonella infection.

Author information

Department of Microbiology, Miami University, Oxford, OH, 45056, USA.
Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0QQ, UK.
Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK.
MRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.
Cambridge Institute for Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge, Cambridge, UK.


SLAMF9 is an orphan receptor of the CD2/SLAM family of leucocyte surface proteins. Examination of SLAMF9 expression and function indicates that SLAMF9 promotes inflammation by specialized subsets of antigen presenting cells. Within healthy liver and circulating mouse PBMCs, SLAMF9 is expressed on CD11b+, Ly6C-, CD11clow , F4/80low , MHC-II+, CX3 CR1+ mononuclear phagocytes as well as plasmacytoid dendritic cells. In addition, SLAMF9 can be found on peritoneal B1 cells and small (F4/80low ), but not large (F4/80high ), peritoneal macrophages. Upon systemic challenge with Salmonella enterica Typhimurium, Slamf9-/- mice were impaired in their ability to clear the infection from the liver. In humans, SLAMF9 is up-regulated upon differentiation of monocytes into macrophages, and LPS stimulation of PMA-differentiated, SLAMF9 knockdown THP-1 cells showed an essential role of SLAMF9 in production of GM-CSF, TNFα, and IL-1β. Taken together, these data implicate SLAMF9 in the initiation of inflammation and clearance of bacterial infection.


SLAMF9; Salmonella; dendritic cells; inflammation; mononuclear phagocytes


Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center